PAOG Signs Agreement with Clinical Research Organization for Advancing Regulatory Approval Procedures

shot by IP News Shots / 10:27 am on 26 October, 2020

The PAO Group Inc. has signed a master services agreement with a clinical research organization (CRO) for the initiation of Investigational New Drug (IND) application with the US Food and Drugs Administration (FDA). The agreement is to work on advancing respiratory cannabis treatment with regulatory approvals.

Read More at: https://finance.yahoo.com/news/paog-announces-cro-agreement-advance-152700404.html

Industry: Biotechnology | Type of IP: Deals - Other Collaborations